Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to -$42.8 million.

  • Biodesix's Income from Continuing Operations rose 14.17% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 8.24%. This contributed to the annual value of -$42.8 million for FY2024, which is 15.96% up from last year.
  • Per Biodesix's latest filing, its Income from Continuing Operations stood at -$42.8 million for FY2024, which was up 15.96% from -$50.9 million recorded in FY2023.
  • Biodesix's 5-year Income from Continuing Operations high stood at -$30.5 million for FY2020, and its period low was -$58.7 million during FY2022.
  • For the 3-year period, Biodesix's Income from Continuing Operations averaged around -$50.8 million, with its median value being -$50.9 million (2023).
  • In the last 5 years, Biodesix's Income from Continuing Operations crashed by 48.91% in 2021 and then climbed by 15.96% in 2024.
  • Over the past 5 years, Biodesix's Income from Continuing Operations (Yearly) stood at -$30.5 million in 2020, then crashed by 48.91% to -$45.4 million in 2021, then fell by 29.07% to -$58.7 million in 2022, then rose by 13.26% to -$50.9 million in 2023, then climbed by 15.96% to -$42.8 million in 2024.